Computational methods directed towards drug repurposing for COVID-19: advantages and limitations-Reference-Cited by-同舟云学术

Computational methods directed towards drug repurposing for COVID-19: advantages and limitations

Published:2021 Issue:57 Volume:11 Page:36181-36198
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Sharma Prem Prakash¹,Bansal Meenakshi¹^ORCID,Sethi Aaftaab²,Poonam ³^ORCID,Pena Lindomar⁴,Goel Vijay Kumar⁵,Grishina Maria⁶,Chaturvedi Shubhra⁷,Kumar Dhruv⁸,Rathi Brijesh¹^ORCID

Affiliation:

1. Laboratory For Translational Chemistry and Drug Discovery, Department of Chemistry, Hansraj College, University of Delhi, Delhi, 110007, India

2. Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India

3. Department of Chemistry, Miranda House, University of Delhi, Delhi, 110007 India

4. Department of Virology, Aggeu Magalhaes, Institute (IAM), Oswaldo Cruz Foundation (Fiocruz), Recife 50670-420, Pernambuco, Brazil

5. School of Physical Sciences, Jawaharlal Nehru University, New Delhi, 110067, India

6. South Ural State University, Laboratory of Computational Modelling of Drugs, Pr. Lenina, 76 454080, Russia

7. Division of Cyclotron and Radiopharmaceutical Sciences, Institute of Nuclear Medicine and Allied Sciences, New Delhi 110054, India

8. Amity Institute of Molecular Medicine & Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida 201313, India

Abstract

Different kind of methods utilized in expediting drug repurposing.

Funder

Russian Foundation for Basic Research

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2021/RA/D1RA05320E

Reference79 articles.

1. Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018

2. M.Placchi and R. J.Phillips , The Benefits and Pitfalls of Repurposing Drugs , https://oliver-dev.s3.amazonaws.com/2018/11/07/21/59/08/240/Benefits%20and%20Pitfalls%20of%20Repurposing%20Drugs.pdf , accessed Febuary 26, 2021

3. Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing

4. Identification of SARS-CoV-2 entry inhibitors among already approved drugs

5. S.Naylor and J. M.Schonfeld , Therapeutic Drug Repurposing, Repositioning and Rescue Part I: Overview , https://www.ddw-online.com/therapeutic-drug-repurposing-repositioning-and-rescue-part-i-overview-1463-201412/ , accessed March15, 2021

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing FDA-approved drugs as NLRP3 inhibitors against inflammatory diseases: machine learning and molecular simulation approaches;Journal of Biomolecular Structure and Dynamics;2024-02-24

2. A comprehensive review on structural and therapeutical insight of Cerebroside sulfotransferase (CST) - An important target for development of substrate reduction therapy against metachromatic leukodystrophy;International Journal of Biological Macromolecules;2024-02

3. In Silico Methods Used in Drug Repurposing;Drug Repurposing;2024

4. Drug Repurposing: History, Significance, Benefits, Approaches, and Challenges;Drug Repurposing;2024

5. Computational Approaches for the Inhibition of ESKAPE Pathogens;ESKAPE Pathogens;2024